Skip to main content
SpringerLink
Log in

Strategies to Improve Adherence to Supplemental Oxygen Therapy

  • Chapter
  • First Online:
Enhancing Patient Engagement in Pulmonary Healthcare

Part of the book series: Respiratory Medicine ((RM))

  • 537 Accesses

Abstract

The prescription of home oxygen for chronic lung disease patients is life-changing for patients and their families. Home oxygen therapy is a physically cumbersome and socially significant treatment, as well as an emotional one that announces disease progression. Existing evidence for the benefits of home oxygen has large gaps and varies across diagnoses; yet, for many patients, oxygen provides the sole treatment for palliation of breathlessness, fatigue, and anxiety. The problems reported by patients using supplemental oxygen have added to our understanding of barriers to adherence and include inadequate and late education, equipment restrictions, and poor communication and problem-solving strategies with healthcare professionals and oxygen suppliers. Healthcare professionals are often unprepared and uninformed regarding regulatory and reimbursement realities, and inadequate equipment and services from durable medical equipment companies that now define ambulatory oxygen. Larger portable systems may negatively affect adherence, physical activity, and HRQoL. Potential life-changing consequences of home oxygen therapy include loss of independence and ability to safely and comfortably leave home for extended periods, engage socially, work, and exercise. Successful use of home oxygen therapy is multifactorial and requires early interventions including patient and family education, and communication between the patient, healthcare professional, and oxygen supplier.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Doherty DE, Petty TL, Bailey W, Carlin B, Cassaburi R, Christopher K, et al. Recommendations of the 6th long-term oxygen therapy consensus conference. Respir Care. 2006;51(5):519–25.

    PubMed  Google Scholar 

  2. McDonald CF, Whyte K, Jenkins S, Serginson J, Frith P. Clinical practice guideline on adult domiciliary oxygen therapy: executive summary from the thoracic society of Australia and New Zealand. Respirology. 2016;21(1):76–8.

    PubMed  Google Scholar 

  3. Hardinge M, Suntharalingam J, Wilkinson T, British Thoracic Society. Guideline update: the British Thoracic Society guidelines on home oxygen use in adults. Thorax. 2015;70(6):589–91.

    PubMed  Google Scholar 

  4. Lacasse Y, Bernard S, Maltais F. Eligibility for home oxygen programs and funding across Canada. Can Respir J. 2015;22(6):324–30.

    PubMed  PubMed Central  Google Scholar 

  5. Jacobs SS, Lederer DJ, Garvey CM, Hernandez C, Lindell KO, McLaughlin S, et al. Optimizing home oxygen therapy. An official American Thoracic Society workshop report. Ann Am Thorac Soc. 2018;15(12):1369–81.

    PubMed  Google Scholar 

  6. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med. 1980;93(3):391–8.

    Google Scholar 

  7. Stuart-Harris C. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council working party. Lancet. 1981;1(8222):681–6.

    Google Scholar 

  8. Albert RK, Au DH, Blackford AL, Casaburi R, Cooper JA Jr, Criner GJ, et al. A randomized trial of long-term oxygen for COPD with moderate desaturation. N Engl J Med. 2016;375(17):1617–27.

    CAS  PubMed  Google Scholar 

  9. Swigris J. Caution against extrapolating results from the trial of long-term oxygen for chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2017;14(2):296.

    PubMed  Google Scholar 

  10. Du Plessis JP, Fernandes S, Jamal R, Camp P, Johannson K, Schaeffer M, et al. Exertional hypoxemia is more severe in fibrotic interstitial lung disease than in COPD. Respirology. 2018;23:392–8.

    PubMed  Google Scholar 

  11. Hardinge M, Annandale J, Bourne S, Cooper B, Evans A, Freeman D, et al. British Thoracic Society guidelines for home oxygen use in adults. Thorax. 2015;70(Suppl 1):i1–43.

    PubMed  Google Scholar 

  12. Visca D, Mori L, Tsipouri V, Fleming S, Firouzi A, Bonini M, et al. Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial. Lancet Respir Med. 2018;6:759–70.

    PubMed  Google Scholar 

  13. Bell EC, Cox NS, Goh N, Glaspole I, Westall GP, Watson A, et al. Oxygen therapy for interstitial lung disease: a systematic review. Eur Respir Rev. 2017;26(143):160080.

    PubMed  Google Scholar 

  14. Leach RM, Davidson AC, Chinn S, Twort CH, Cameron IR, Bateman NT. Portable liquid oxygen and exercise ability in severe respiratory disability. Thorax. 1992;47(10):781–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Sharp C, Adamali H, Millar AB. Ambulatory and short-burst oxygen for interstitial lung disease. Cochrane Database Syst Rev. 2016;7:CD011716.

    PubMed  Google Scholar 

  16. Frank RC, Hicks S, Duck AM, Spencer L, Leonard CT, Barnett E. Ambulatory oxygen in idiopathic pulmonary fibrosis: of what benefit? Eur Respir J. 2012;40(1):269–70.

    PubMed  Google Scholar 

  17. Visca D, Montgomery A, de Lauretis A, Sestini P, Soteriou H, Maher TM, et al. Ambulatory oxygen in interstitial lung disease. Eur Respir J. 2011;38(4):987–90.

    CAS  PubMed  Google Scholar 

  18. Morrison DA, Stovall JR. Increased exercise capacity in hypoxemic patients after long-term oxygen therapy. Chest. 1992;102(2):542–50.

    CAS  PubMed  Google Scholar 

  19. Emtner M, Porszasz J, Burns M, Somfay A, Casaburi R. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med. 2003;168(9):1034–42.

    PubMed  Google Scholar 

  20. O’Donnell DE, Bain DJ, Webb KA. Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. Am J Respir Crit Care Med. 1997;155(2):530–5.

    PubMed  Google Scholar 

  21. Jolly EC, Di Boscio V, Aguirre L, Luna CM, Berensztein S, Gene RJ. Effects of supplemental oxygen during activity in patients with advanced COPD without severe resting hypoxemia. Chest. 2001;120(2):437–43.

    CAS  PubMed  Google Scholar 

  22. Lacasse Y, Tan AM, Maltais F, Krishnan JA. Home oxygen in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;197(10):1254–64.

    CAS  PubMed  Google Scholar 

  23. Casaburi R, Porszasz J, Hecht A, Tiep B, Albert RK, Anthonisen NR, et al. Influence of lightweight ambulatory oxygen on oxygen use and activity patterns of COPD patients receiving long-term oxygen therapy. COPD. 2012;9(1):3–11.

    PubMed  Google Scholar 

  24. Lacasse Y, Lecours R, Pelletier C, Begin R, Maltais F. Randomised trial of ambulatory oxygen in oxygen-dependent COPD. Eur Respir J. 2005;25(6):1032–8.

    CAS  PubMed  Google Scholar 

  25. Vergeret J, Brambilla C, Mounier L. Portable oxygen therapy: use and benefit in hypoxaemic COPD patients on long-term oxygen therapy. Eur Respir J. 1989;2(1):20–5.

    CAS  PubMed  Google Scholar 

  26. McDonald CF, Blyth CM, Lazarus MD, Marschner I, Barter CE. Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxemia. Am J Respir Crit Care Med. 1995;152(5 Pt 1):1616–9.

    CAS  PubMed  Google Scholar 

  27. Nonoyama ML, Brooks D, Guyatt GH, Goldstein RS. Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia. Am J Respir Crit Care Med. 2007;176(4):343–9.

    PubMed  Google Scholar 

  28. Moore RP, Berlowitz DJ, Denehy L, Pretto JJ, Brazzale DJ, Sharpe K, et al. A randomised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia. Thorax. 2011;66(1):32–7.

    PubMed  Google Scholar 

  29. Kantorowski A, Wan ES, Homsy D, Kadri R, Richardson CR, Moy ML. Determinants and outcomes of change in physical activity in COPD. ERJ Open Res. 2018;4(3):00054-2018.

    PubMed  PubMed Central  Google Scholar 

  30. Jacobs SS, Lindell KO, Collins EG, Garvey CM, Hernandez C, McLaughlin S, et al. Patient perceptions of the adequacy of supplemental oxygen therapy. Results of the American Thoracic Society nursing assembly oxygen working group survey. Ann Am Thorac Soc. 2018;15(1):24–32.

    PubMed  Google Scholar 

  31. Mussa CC, Tonyan L, Chen YF, Vines D. Perceived satisfaction with long-term oxygen delivery devices affects perceived mobility and quality of life of oxygen-dependent individuals with COPD. Respir Care. 2018;63(1):11–9.

    PubMed  PubMed Central  Google Scholar 

  32. AlMutairi HJ, Mussa CC, Lambert CT, Vines DL, Strickland SL. Perspectives from COPD subjects on portable long-term oxygen therapy devices. Respir Care. 2018;63(11):1321–30.

    PubMed  Google Scholar 

  33. Lindell KO, Collins EG, Catanzarite L, Garvey CM, Hernandez C, McLaughlin S, et al. Equipment, access and worry about running short of oxygen: key concerns in the ATS patient supplemental oxygen survey. Heart Lung. 2019;48:245–9.

    CAS  PubMed  Google Scholar 

  34. Swigris JJ. Transitions and touchpoints in idiopathic pulmonary fibrosis. BMJ Open Respir Res. 2018;5(1):e000317.

    PubMed  PubMed Central  Google Scholar 

  35. Eaton T, Lewis C, Young P, Kennedy Y, Garrett JE, Kolbe J. Long-term oxygen therapy improves health-related quality of life. Respir Med. 2004;98(4):285–93.

    CAS  PubMed  Google Scholar 

  36. Borak J, Sliwinski P, Tobiasz M, Gorecka D, Zielinski J. Psychological status of COPD patients before and after one year of long-term oxygen therapy. Monaldi Arch Chest Dis = Arch Monaldi Mal Torace. 1996;51(1):7–11.

    CAS  Google Scholar 

  37. Belkin A, Albright K, Swigris JJ. A qualitative study of informal caregivers’ perspectives on the effects of idiopathic pulmonary fibrosis. BMJ Open Respir Res. 2014;1(1):e000007.

    PubMed  PubMed Central  Google Scholar 

  38. Lindell KO, Catazanarite L, Collins EG, Garvey CM, Hernandez C, McLaughlin S, Schneidman AM, Meek PM, Jacobs SS. Equipment, access and worry about running short of oxygen: key concerns in the patient supplemental oxygen survey. Am J Respir Crit Care Med. 2017;195:A7646.

    Google Scholar 

  39. Gloeckl R, Osadnik C, Bies L, Leitl D, Koczulla AR, Kenn K. Comparison of continuous flow versus demand oxygen delivery systems in patients with COPD: a systematic review and meta-analysis. Respirology. 2019;24(4):329–37.

    PubMed  Google Scholar 

  40. Katsenos S, Constantopoulos SH. Long-term oxygen therapy in COPD: factors affecting and ways of improving patient compliance. Pulm Med. 2011;2011:325362.

    PubMed  PubMed Central  Google Scholar 

  41. Gauthier A, Bernard S, Bernard E, Simard S, Maltais F, Lacasse Y. Adherence to long-term oxygen therapy in patients with chronic obstructive pulmonary disease. Chron Respir Dis. 2018;16:1479972318767724.

    PubMed  PubMed Central  Google Scholar 

  42. Pepin JL, Barjhoux CE, Deschaux C, Brambilla C. Long-term oxygen therapy at home. Compliance with medical prescription and effective use of therapy. ANTADIR working group on oxygen therapy. Association Nationale de Traitement a Domicile des Insuffisants Respiratories. Chest. 1996;109(5):1144–50.

    CAS  PubMed  Google Scholar 

  43. Peckham DG, McGibbon K, Tonkinson J, Plimbley G, Pantin C. Improvement in patient compliance with long-term oxygen therapy following formal assessment with training. Respir Med. 1998;92(10):1203–6.

    CAS  PubMed  Google Scholar 

  44. Moy ML, Harrington KF, Sternberg AL, Krishnan JA, Albert RK, Au DH, et al. Characteristics at the time of oxygen initiation associated with its adherence: findings from the COPD Long-term Oxygen Treatment Trial. Respir Med. 2019;149:52–8.

    PubMed  PubMed Central  Google Scholar 

  45. Kelly CA, Lynes D, O’Brien MR, Shaw B. A wolf in sheep’s clothing? Patients’ and healthcare professionals’ perceptions of oxygen therapy: an interpretative phenomenological analysis. Clin Respir J. 2018;12(2):616–32.

    PubMed  Google Scholar 

  46. Khor YH, Goh NSL, McDonald CF, Holland AE. Oxygen therapy for interstitial lung disease. A mismatch between patient expectations and experiences. Ann Am Thorac Soc. 2017;14(6):888–95.

    PubMed  Google Scholar 

  47. Graney BA, Wamboldt FS, Baird S, Churney T, Fier K, Korn M, et al. Looking ahead and behind at supplemental oxygen: a qualitative study of patients with pulmonary fibrosis. Heart Lung. 2017;46(5):387–93.

    PubMed  Google Scholar 

  48. Hernandez C, Aibar J, de Batlle J, Gomez-Cabrero D, Soler N, Duran-Tauleria E, et al. Assessment of health status and program performance in patients on long-term oxygen therapy. Respir Med. 2015;109(4):500–9.

    PubMed  Google Scholar 

  49. Kelly CA, Maden M. How do respiratory patients perceive oxygen therapy? A critical interpretative synthesis of the literature. Chron Respir Dis. 2014;11(4):209–28.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pulmonary, Allergy and Critical Care Medicine, Stanford University, Stanford, CA, USA

    Susan S. Jacobs

  2. Sleep Disorders and Pulmonary Rehabilitation, University of California, San Francisco, CA, USA

    Chris Garvey

Authors
  1. Susan S. Jacobs
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chris Garvey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Susan S. Jacobs .

Editor information

Editors and Affiliations

  1. Harvard Medical School, Boston, MA, USA

    Marilyn L. Moy

  2. School of Science & Health, Western Sydney University, Penrith, NSW, Australia

    Felicity Blackstock

  3. Providence VA Medical Center, Providence, RI, USA

    Linda Nici

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Jacobs, S.S., Garvey, C. (2020). Strategies to Improve Adherence to Supplemental Oxygen Therapy. In: Moy, M., Blackstock, F., Nici, L. (eds) Enhancing Patient Engagement in Pulmonary Healthcare. Respiratory Medicine. Humana, Cham. https://doi.org/10.1007/978-3-030-44889-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-44889-9_10

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-44888-2

  • Online ISBN: 978-3-030-44889-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation